Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / GLOBAL EX US HGH
-
Total 13F shares
-
4,070,147
-
Share change
-
-20,520
-
Total reported value
-
$81,302,130
-
Price per share
-
$19.77
-
Number of holders
-
56
-
Value change
-
-$1,039,338
-
Number of buys
-
25
-
Number of sells
-
28
Institutional Holders of INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) as of Q1 2020
As of 31 Mar 2020,
INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,070,147 shares.
The largest 10 holders included
Maxim Capital Management LLC, CENTAURUS FINANCIAL, INC., 6 Meridian, CABOT WEALTH MANAGEMENT INC, AlphaStar Capital Management, LLC, JANE STREET GROUP, LLC, Eqis Capital Management, Inc., MORGAN STANLEY, Madrona Financial Services, LLC, and CITADEL ADVISORS LLC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.